Research partially funded by the JKTG Foundation recently appeared recently in the Bulletin of Mathematical Biology.
The research, Intermittent Hormone Therapy Models Analysis and Bayesian Model Comparison for Prostate Cancer, includes work by Heiko Enderling, Ph.D., a researcher with whom JKTG has worked on several projects.
As described in the published abstract, first-line therapy for prostate cancer includes androgen deprivation therapy (ADT), depriving both the normal and malignant prostate cells of androgens required for proliferation and survival.
In recent years, intermittent ADT has been proposed as an alternative to continuous ADT. Several mathematical models with different biological resistance mechanisms have been considered to simulate intermittent ADT response dynamics.
The research compares 13 intermittent dynamical models and assess their ability to describe prostate-specific antigen (PSA) dynamics.
Featured news
Ted’s Take: Why insurance companies pay more than Medicare
When you go to buy a car, there’s often a difference between what a car dealership charges – the sticker on the car window – versus what you end up paying. Few people consider this same concept applies to health care.
Ted’s Take: What is your role in health and health equity?
As we talk and plan for improvements in virtually anything, it’s important that we examine what our role in that process is and should be.
Ted’s Take: Medicare for all – HUH?
Around every national election, the phrase Medicare for All comes up. My reaction is simple: HUH? Here’s why?
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133